🇯🇵·10h agoRegulatory
[ANZEN]Revisions of PRECAUTIONS: Lithium carbonate , etc. posted
Publisher
P
PMDA Japan
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- PMDA Japan
- Region
- Japan
- Scope
- Regulatory
- Published
- June 16, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on pmda.go.jp
Leave the platform to read the original full article on the publisher site.
Source: PMDA Japan
Scope: Regulatory
Related coverage
More related coverage
MHRA UK·2h ago
Class 3 Medicines Recall: Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml Solution for injection, EL(26)A/29
IFPMA Global·2h ago
High-Level Virtual Meeting of African Heads of States, Governments and Partners on Ebola Bundibugyo virus disease outbreak
LEEM France·3h ago
INVITATION CONFERENCE DE PRESSE : Résultats 2026 du baromètre 360° de l’attractivité de la France pour l’industrie pharmaceutique
PMDA Japan·10h ago